Immunological Response to COVID-19 Vaccination in Ovarian Cancer Patients Receiving PARP Inhibitors

Objective: Vaccination for SARS-CoV-2 provides significant protection against the infection in the general population. However, limited data exist for cancer patients under systemic therapy. Methods: In this cohort, we prospectively enrolled cancer patients treated with PARPi as well as healthy volu...

Descripción completa

Detalles Bibliográficos
Autores principales: Liontos, Michalis, Terpos, Evangelos, Markellos, Christos, Zagouri, Flora, Briasoulis, Alexandros, Katsiana, Ioanna, Skafida, Efthymia, Fiste, Oraianthi, Kunadis, Elena, Andrikopoulou, Angeliki, Kaparelou, Maria, Koutsoukos, Konstantinos, Gavriatopoulou, Maria, Kastritis, Efstathios, Trougakos, Ioannis P., Dimopoulos, Meletios-Athanasios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541338/
https://www.ncbi.nlm.nih.gov/pubmed/34696256
http://dx.doi.org/10.3390/vaccines9101148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541338/
https://www.ncbi.nlm.nih.gov/pubmed/34696256
http://dx.doi.org/10.3390/vaccines9101148

Ejemplares similares